Amyris signs exclusive license agreement with Croda International for sustainable squalene supply
NYBC Ventures Launches Fund with USD 50m from New York Blood Center
Codagenix commences dosing in CodaVax-RSV paediatric Phase one study
Sinovac's CoronaVac addresses Hong Kong's need for self-pay COVID-19 vaccines
Appili Therapeutics Secures Contract for ATI-1701 Funding from the US Air Force Academy
GSK receives FDA approval for world-first RSV vaccine for older adults
GlaxoSmithKline Biologicals' Arexvy receives US FDA approval
P95 BV announces majority recapitalisation by Ampersand Capital Partners